Equities

Cytek Biosciences Inc

Cytek Biosciences Inc

Actions
  • Price (USD)6.55
  • Today's Change0.09 / 1.39%
  • Shares traded496.67k
  • 1 Year change-2.24%
  • Beta1.4216
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue193164128
OPERATING EXPENSES
Cost of revenue total846349
Selling, general and admin. expenses, total936845
Depreciation/amortization------
Unusual expense(income)----0.23
Other operating expenses, total------
Total operating expense221166119
Operating income(28)(1.8)9.16
Other, net7.831.06(1.49)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes(16)1.265.94
Provision for income taxes(3.56)(1.22)2.91
Net income after taxes(12)2.483.03
Minority interest00.09(0.03)
Net income before extra. Items(12)2.583.00
Total extraordinary items------
Net income(12)2.583.00
Inc.avail. to common excl. extra. Items(12)2.580
Inc.avail. to common incl. extra. Items(12)2.580
EPS RECONCILIATION
Basic/primary weighted average shares13513577
Basic/primary eps excl. extra items(0.09)0.020
Basic/primary eps incl. extra items(0.09)0.020
Dilution adjustment------
Diluted weighted average shares13513982
Diluted eps excl. extra items(0.09)0.020
Diluted eps incl. extra items(0.09)0.020
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental2.072.571.74
SUPPLEMENTAL INCOME
Depreciation, supplemental2.801.700.91
Total special items----0.23
NORMALISED INCOME
Normalized income before taxes(16)1.266.17
Effect of special items on income taxes----0.11
Income tax excluding impact of special items(3.56)(1.22)3.02
Normalized income after tax(12)2.483.14
Normalized income avail. to common(12)2.580.12
Basic normalized EPS(0.09)0.020.00
Diluted normalized EPS(0.09)0.020.00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.